Nosocomial transmission of Cupriavidus pauculus during extracorporeal membrane oxygenation.
Patients undergoing extracorporeal membrane oxygenation (ECMO) are at increased risk of infection. We present the first known report of nosocomial infection with Cupriavidus pauculus attributable to contamination from ECMO equipment and describe the measures taken to halt subsequent infections. A cluster of infections in ECMO patients should prompt team members to consider contamination of equipment with environmental pathogens as a possible cause.
Stovall
S H
SH
University of Arkansas for Medical Sciences, Little Rock, 72202, USA. stovallstephanieh@uams.edu
Wisdom
C
C
McKamie
W
W
Ware
W
W
Dedman
H
H
Fiser
R T
RT
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000077723:Cefepime; D002511:Cephalosporins / Q000627:therapeutic use; D002675:Child, Preschool; D002939:Ciprofloxacin / Q000627:therapeutic use; D003428:Cross Infection / Q000188:drug therapy / Q000382:microbiology*; D049921:Cupriavidus; D004866:Equipment Contamination; D015199:Extracorporeal Membrane Oxygenation / Q000009:adverse effects*; D005839:Gentamicins / Q000627:therapeutic use; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D000077731:Meropenem; D010397:Penicillanic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D010878:Piperacillin / Q000627:therapeutic use; D000078142:Tazobactam; D013845:Thienamycins / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D005839:Gentamicins; D013845:Thienamycins; D002939:Ciprofloxacin; D000077723:Cefepime; D010397:Penicillanic Acid; D000077731:Meropenem; D000078142:Tazobactam; D010878:Piperacillin